American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes-Reference-Cited by-同舟云学术

American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes

Published:2014-04-20 Issue:12 Volume:32 Page:1277-1280
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ellis Lee M.¹,Bernstein David S.¹,Voest Emile E.¹,Berlin Jordan D.¹,Sargent Daniel¹,Cortazar Patricia¹,Garrett-Mayer Elizabeth¹,Herbst Roy S.¹,Lilenbaum Rogerio C.¹,Sima Camelia¹,Venook Alan P.¹,Gonen Mithat¹,Schilsky Richard L.¹,Meropol Neal J.¹,Schnipper Lowell E.¹

Affiliation:

1. Lee M. Ellis, University of Texas MD Anderson Cancer Center, Houston, TX; David S. Bernstein and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Emile E. Voest, University Medical Center Utrecht, Utrecht, the Netherlands; Jordan D. Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Daniel Sargent, Mayo Clinic, Rochester, MN; Patricia Cortazar, US Food and Drug Administration, Silver Spring, MD; Elizabeth Garrett-Mayer, Medical University of South Carolina, Charleston, SC;...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.53.8009

Reference27 articles.

1. Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome

2. Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

4. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration;Scientific Reports;2024-01-03

2. Association of possible sarcopenia with all-cause mortality in patients with solid cancer: A nationwide multicenter cohort study;The Journal of nutrition, health and aging;2024-01

3. Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer;Clinical Colorectal Cancer;2023-12

4. Treating metastatic pancreatic ductal adenocarcinoma: NALIRIFOX as new standard?;The Lancet;2023-10

5. Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma;JAMA Oncology;2023-10-01